4.7 Article

Mammalian Target of Rapamycin Is a Critical Regulator of Cardiac Hypertrophy in Spontaneously Hypertensive Rats

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: A 1-year nonrandomized controlled trial

Ernesto Paoletti et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2008)

Article Cardiac & Cardiovascular Systems

Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients

Sudhir S. Kushwaha et al.

EUROPEAN HEART JOURNAL (2008)

Article Peripheral Vascular Disease

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

Xiao-Ming Gao et al.

JOURNAL OF HYPERTENSION (2006)

Article Cardiac & Cardiovascular Systems

Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction

Thunder Jalili et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)

Article Cell Biology

Protein kinase C isozymes in hypertension and hypertrophy: Insight from SHHF rat hearts

DD Johnsen et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)

Article Biochemistry & Molecular Biology

PKC-α regulates cardiac contractility and propensity toward heart failure

JC Braz et al.

NATURE MEDICINE (2004)

Article Biochemistry & Molecular Biology

The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110α) pathway

JR McMullen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Cardiac & Cardiovascular Systems

Protein kinase Cα negatively regulates systolic and diastolic function in pathological hypertrophy

HS Hahn et al.

CIRCULATION RESEARCH (2003)

Article Cardiac & Cardiovascular Systems

Rapamycin attenuates load-induced cardiac hypertrophy in mice

T Shioi et al.

CIRCULATION (2003)

Article Cardiac & Cardiovascular Systems

Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril

SD Sarkissian et al.

CARDIOVASCULAR RESEARCH (2003)

Article Cardiac & Cardiovascular Systems

Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats;: Differential effects on PKCε and PKCβ

K Inagaki et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)

Article Biochemistry & Molecular Biology

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

T Matsui et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

Akt/Protein kinase B promotes organ growth in transgenic mice

T Shioi et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)

Article Multidisciplinary Sciences

Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and εPKC

L Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Cardiac & Cardiovascular Systems

PKC-β is not necessary for cardiac hypertrophy

BB Roman et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)

Article Biochemistry & Molecular Biology

The conserved phosphoinositide 3-kinase pathway determines heart size in mice

T Shioi et al.

EMBO JOURNAL (2000)